Katherine Tkaczuk

416 total citations
18 papers, 326 citations indexed

About

Katherine Tkaczuk is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Katherine Tkaczuk has authored 18 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Cancer Research. Recurrent topics in Katherine Tkaczuk's work include Breast Cancer Treatment Studies (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Estrogen and related hormone effects (3 papers). Katherine Tkaczuk is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Estrogen and related hormone effects (3 papers). Katherine Tkaczuk collaborates with scholars based in United States, United Kingdom and Palestinian Territory. Katherine Tkaczuk's co-authors include Min Zhan, Reneé Royak-Schaler, Ginette Serrero, Binbin Yue, Lisa Gallicchio, Lynn M. Lewis, Jodi A. Flaws, Susan Racine Passmore, Shahinaz M. Gadalla and M. Katherine Hoy and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Katherine Tkaczuk

18 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine Tkaczuk United States 9 161 105 52 43 42 18 326
Martin Paton United Kingdom 8 113 0.7× 370 3.5× 52 1.0× 84 2.0× 19 0.5× 19 597
I Boland France 11 140 0.9× 207 2.0× 146 2.8× 25 0.6× 56 1.3× 15 533
T. Cerny Switzerland 15 131 0.8× 71 0.7× 22 0.4× 11 0.3× 71 1.7× 23 406
Kai‐Bin Yang China 10 141 0.9× 142 1.4× 49 0.9× 35 0.8× 61 1.5× 20 400
Michal A. Miller United States 8 102 0.6× 109 1.0× 41 0.8× 9 0.2× 17 0.4× 15 298
Ehsan Zaboli Iran 9 105 0.7× 60 0.6× 25 0.5× 11 0.3× 45 1.1× 48 283
Jianjun Gu China 12 48 0.3× 135 1.3× 24 0.5× 15 0.3× 42 1.0× 25 352
Xiangdong Lu China 12 125 0.8× 255 2.4× 11 0.2× 36 0.8× 40 1.0× 24 455
P R Taylor United Kingdom 11 137 0.9× 158 1.5× 19 0.4× 38 0.9× 25 0.6× 20 517
Charmaine Martin United States 4 185 1.1× 125 1.2× 15 0.3× 60 1.4× 47 1.1× 6 412

Countries citing papers authored by Katherine Tkaczuk

Since Specialization
Citations

This map shows the geographic impact of Katherine Tkaczuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Tkaczuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Tkaczuk more than expected).

Fields of papers citing papers by Katherine Tkaczuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Tkaczuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Tkaczuk. The network helps show where Katherine Tkaczuk may publish in the future.

Co-authorship network of co-authors of Katherine Tkaczuk

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Tkaczuk. A scholar is included among the top collaborators of Katherine Tkaczuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Tkaczuk. Katherine Tkaczuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
3.
Bentzen, Søren M., J.W. Snider, Susan B. Kesmodel, et al.. (2017). The Initial Clinical Experience of a Novel Breast Specific Stereotactic Radiosurgery Device. International Journal of Radiation Oncology*Biology*Physics. 99(2). E14–E15. 1 indexed citations
4.
Molitoris, Jason K., Tejan Diwanji, J.W. Snider, et al.. (2017). Increasing utilization of regional nodal irradiation in elderly node-positive women and declining emphasis on demographic factors. Breast Cancer Research and Treatment. 165(3). 669–676. 3 indexed citations
5.
Cohen, Jerry D., J.W. Snider, Jason K. Molitoris, et al.. (2017). Positron Emission Tomography/Computed Tomography (PET/CT) in the Initial Evaluation of Women with Nonmetastatic Breast Cancer Can Frequently Alter Management. International Journal of Radiation Oncology*Biology*Physics. 99(2). E25–E26. 1 indexed citations
6.
Serrero, Ginette, Douglas M. Hawkins, P.A. Bejarano, et al.. (2016). Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index. Diagnostic Pathology. 11(1). 71–71. 8 indexed citations
7.
Sun, Wenji, Yi Wang, James E. East, et al.. (2015). Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional. Cytokine. 72(1). 48–57. 11 indexed citations
8.
Chumsri, Saranya, Gauri Sabnis, Katherine Tkaczuk, & Angela Brodie. (2014). mTOR inhibitors: Changing Landscape of Endocrine-Resistant Breast Cancer. Future Oncology. 10(3). 443–456. 8 indexed citations
9.
Sohn, Silke, et al.. (2014). Development of a qPCR method to rapidly assess the function of NKT cells. Journal of Immunological Methods. 407. 82–89. 4 indexed citations
10.
Serrero, Ginette, Douglas M. Hawkins, Binbin Yue, et al.. (2012). Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma. Breast Cancer Research. 14(1). R26–R26. 48 indexed citations
11.
Tkaczuk, Katherine, Binbin Yue, Min Zhan, et al.. (2011). Increased Circulating Level of the Survival Factor GP88 (Progranulin) in the Serum of Breast Cancer Patients When Compared to Healthy Subjects. Breast Cancer Basic and Clinical Research. 5. BCBCR.S7224–BCBCR.S7224. 37 indexed citations
12.
Feigenberg, Steven J., et al.. (2011). Preliminary Results of a Prospective Feasibility Study Testing Preoperative Accelerated Partial Breast Radiotherapy (APBI) Using 3 Dimensional Conformal Radiotherapy (3D CRT). International Journal of Radiation Oncology*Biology*Physics. 81(2). S264–S264. 1 indexed citations
13.
Serrero, Ginette, et al.. (2009). Elevated serum levels of the growth factor GP88 are found in breast cancer patients when compared to healthy individuals.. Cancer Research. 69(2_Supplement). 2006–2006. 1 indexed citations
14.
Royak-Schaler, Reneé, Susan Racine Passmore, Shahinaz M. Gadalla, et al.. (2008). Exploring Patient-Physician Communication in Breast Cancer Care for African American Women Following Primary Treatment. Oncology nursing forum. 35(5). 836–843. 67 indexed citations
15.
Zhan, Min, Jodi A. Flaws, Lisa Gallicchio, et al.. (2007). Profiles of tamoxifen-related side effects by race and smoking status in women with breast cancer. Cancer Detection and Prevention. 31(5). 384–390. 22 indexed citations
16.
Gallicchio, Lisa, Gwyn A. Lord, Katherine Tkaczuk, et al.. (2004). Association of Tamoxifen (TAM) and TAM Metabolite Concentrations with Self-Reported Side Effects of TAM in Women with Breast Cancer. Breast Cancer Research and Treatment. 85(1). 89–97. 38 indexed citations
17.
Toppmeyer, Deborah, Andrew D. Seidman, Michaël Pollak, et al.. (2002). Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel.. PubMed. 8(3). 670–8. 61 indexed citations
18.
Nemunaitis, John, A. Corey, Katherine Tkaczuk, et al.. (2000). Phase I Assessment of the Pharmacokinetics, Metabolism, and Safety of Emitefur in Patients With Refractory Solid Tumors. Journal of Clinical Oncology. 18(19). 3423–3434. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Paton Breakdown of academic impact, for papers by I Boland Breakdown of academic impact, for papers by T. Cerny Breakdown of academic impact, for papers by Kai‐Bin Yang Breakdown of academic impact, for papers by Michal A. Miller Breakdown of academic impact, for papers by Ehsan Zaboli Breakdown of academic impact, for papers by Jianjun Gu Breakdown of academic impact, for papers by Xiangdong Lu Breakdown of academic impact, for papers by P R Taylor Breakdown of academic impact, for papers by Charmaine Martin
Rankless by CCL
2026